News Daily News Lower Dose of Edoxaban Supported in ENGAGE-AF-TIMI 48 Analysis Todd Neale March 02, 2021
News Daily News CTA Matches Invasive Angiography for Stratification of NSTE ACS Risk Yael L. Maxwell February 23, 2021
News Daily News CV Complications of Malaria Rare but Portend Poor Prognosis Michael O'Riordan February 22, 2021
News Daily News Rivaroxaban-Aspirin Combo Works in ASCVD Across BMI Groups Todd Neale February 01, 2021
News Daily News One by One, Risk Factors Have Additive Impact on Cardiac Arrest Survival Caitlin E. Cox January 25, 2021
News Daily News TAVI vs Minimally Invasive AVR Yields Surprising Findings: Meta-analysis Yael L. Maxwell January 22, 2021
News Daily News New Advanced Training Outlined for Future Vascular Medicine Specialists Michael O'Riordan January 21, 2021
News Daily News Cerebral Embolic Protection Use Low During TAVI, Not Tied to Stroke Risk Todd Neale January 20, 2021
News Daily News REPLACE COVID Bolsters Advice to Continue RAAS Inhibitors in COVID-19 Patients Todd Neale January 13, 2021
News Daily News ACC’s HFrEF Update Includes ARNI, SGLT2 Inhibitor Trials Plus Tips for Care L.A. McKeown January 11, 2021
News Daily News ACC Issues New Guidance Around Antithrombotic Choices in A-fib, VTE Todd Neale December 22, 2020
News Daily News Cardiac Transplant Patients at Higher Risk for COVID-19, Death Caitlin E. Cox December 09, 2020
News Daily News Stroke After PCI, CABG Signals Higher Long-term Mortality in Modern Era Todd Neale December 08, 2020
News Daily News Nationwide Data Shed Light on Timing, Predictors of Acute MI in Pregnancy Caitlin E. Cox November 03, 2020
News Daily News Features of Complex CAD Carry Progressive Risk in PCI, Registry Confirms Caitlin E. Cox October 08, 2020
News Daily News No Gains From Early Angiography After Cardiac Arrest Without STEMI Todd Neale October 06, 2020
News Daily News Fewer MACE in Diabetic Patients Taking SGLT2 Inhibitors vs DPP-4 Inhibitors Shelley Wood September 30, 2020
News Daily News VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks Michael O'Riordan September 24, 2020